Select Medical Holdings Corporation (NYSE:SEM) Navigates Mixed Q1 Earnings and Analyst Downgrade

• Select Medical Holdings Corporation (NYSE:SEM) received a "Neutral" rating downgrade from Mizuho Securities, with a price target suggesting limited near-term stock movement.
• The company's first-quarter adjusted earnings of $0.36 per share missed analyst estimates and declined 18.2% year-over-year, primarily due to rising operating expenses.
• Despite the decline in profitability, Select Medical's net operating revenues grew 5% to $1.42 billion, driven by strong performance in its Rehabilitation Hospital segment.

Select Medical Holdings Corporation (NYSE:SEM) is a leading healthcare company that operates specialty hospitals and outpatient rehabilitation clinics across the United States. With a market capitalization of around $2.04 billion, Select Medical is a significant provider of post-acute care services. Its stock currently trades near $16.45 per share.

On May 12, 2026, an analyst from Mizuho Securities downgraded Select Medical to a Neutral rating. This type of rating suggests that the stock is expected to perform in line with the average market return. The analyst also set a price target of $16.50, indicating little expected movement from its price at the time.

This neutral outlook reflects Select Medical's recent financial performance. As highlighted by Zacks, Select Medical reported first-quarter adjusted earnings of $0.36 per share, missing analyst estimates by 16.3%. This figure also represents an 18.2% decline compared to the same quarter in the previous year, showing a drop in profitability.

The lower earnings are a result of rising operating expenses. According to a company announcement highlighted by PR Newswire, income from operations fell to $98.4 million from $112.7 million year-over-year. Net income, which is Select Medical's profit after all expenses, also decreased to $63.8 million from $74.7 million.

Despite the decline in profit, Select Medical's revenue shows a positive trend. Net operating revenues grew 5% year-over-year to $1.42 billion, surpassing expectations. This increase was mainly due to strong performance in its Rehabilitation Hospital segment, which experienced higher patient admissions and occupancy rates.